U-Blot® Research Grade AscrinvacumabCat. No. WA2440$9,999
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade AscrinvacumabCat. No. WA2440
U-Blot® Research Grade arumakimigCat. No. WA2439
U-Blot® Research Grade armocibartCat. No. WA2438
U-Blot® Research Grade aritinerceptCat. No. WA2437
U-Blot® Research Grade Arevirumab-3Cat. No. WA2436
U-Blot® Research Grade arcotatugCat. No. WA2435
U-Blot® Research Grade ArcitumomabCat. No. WA2434
U-Blot® Research Grade AprutumabCat. No. WA2433
U-Blot® Research Grade ApolizumabCat. No. WA2432
U-Blot® Research Grade AplitabartCat. No. WA2431
U-Blot® Research Grade ApitegromabCat. No. WA2430
U-Blot® Research Grade ApamistamabCat. No. WA2429